These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 82285)

  • 1. Nonassociation of hyperamylasemia and prostatic disease.
    Lehner LM; Melman A
    Urology; 1978 Oct; 12(4):461-2. PubMed ID: 82285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incidence of hyperamylasemia in tumor diseases of the prostate].
    Skrha J; Stĕpán J; Vachalovský V; Hradec E; Marek J
    Cas Lek Cesk; 1982 Sep; 121(38-39):1195-8. PubMed ID: 6182997
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible role of amylase enzyme in prostatic and seminal fluid.
    Hanafy HM
    Urol Int; 1979; 34(1):11-4. PubMed ID: 85357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
    Truong T; Carmel M; Elhilali M; Cloutier D; Lehoux JG
    Prostate; 1985; 7(2):143-9. PubMed ID: 2413430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
    Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
    Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urinary amylase isoenzymes in carcinoma of the prostate.
    Skrha J; Stĕpán J; Pacovský V; Vachalovský V; Hradec E
    Clin Chim Acta; 1982 May; 121(1):11-4. PubMed ID: 6177447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1980 Jan; 48(1):65-7. PubMed ID: 6159782
    [No Abstract]   [Full Text] [Related]  

  • 8. A histochemical study of glycosidases in benign prostatic hyperplasia and in prostatic carcinoma in the human.
    Sinowatz F; Weber P; Gasser G; Mossig H; Skolek-Winnisch R
    Urol Res; 1978; 6(2):103-7. PubMed ID: 78561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocitrate dehydrogenase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Leus R; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Jan; 49(1):61-3. PubMed ID: 6163342
    [No Abstract]   [Full Text] [Related]  

  • 10. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased serum amylase levels in prostatic diseases.
    Hanafy HM; Gursel EO; Veenema RJ
    Urology; 1973 Apr; 1(4):372-3. PubMed ID: 4129262
    [No Abstract]   [Full Text] [Related]  

  • 12. [The distribution of isoenzymes of lactate dehydrogenase in benign and malignant neoplasms of the human prostate (author's transl)].
    Feustel A; Wohlrab F; Paschke P; Zochert G
    Urol Int; 1976; 31(4):302-14. PubMed ID: 61637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperamylasemia in endometrial adenocarcinoma].
    Matsuta M; Murakami K; Ono H; Saitoh S; Nishiya I; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1557-64. PubMed ID: 2479698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LDH index in the diagnosis of prostatic diseases].
    Lalanne MG; De Santis P; Mazzuca A
    Minerva Urol; 1983; 35(4):243-5. PubMed ID: 6201706
    [No Abstract]   [Full Text] [Related]  

  • 16. Lactate dehydrogenase isoenzymes in benign and malignant prostatic tissues.
    Mazzuca A; Lalanne GM
    Boll Soc Ital Biol Sper; 1980 Apr; 56(7):690-2. PubMed ID: 6160867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
    Zang T; Sun F; Li Y
    Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.
    Homburger HA; Miller SA; Jacob GL
    Clin Chem; 1980 Dec; 26(13):1821-4. PubMed ID: 6159995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
    Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
    Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary enzymatic studies of human benign prostate hypertrophy and prostatic cancer.
    Miller HC; Rector W; Hilf R
    Invest Urol; 1972 Jul; 10(1):1-4. PubMed ID: 4114027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.